#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome Inflammatory myofibroblastic tumour Encephalitis autoimmune Waldenstrom's macroglobulinaemia recurrent Laryngeal squamous cell carcinoma Hereditary ataxia Necrotising enterocolitis neonatal Heavy menstrual bleeding Acute respiratory distress syndrome Neurodegenerative disorder Chronic cutaneous lupus erythematosus Infective uveitis Malformation venous Thermal burn Diffuse large B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    CADASIL – Basic Information Indolent systemic mastocytosis – Treatment Malignant fibrous histiocytoma – Life with Disease Factor IX deficiency – Trials in Disease Primary mediastinal large B-cell lymphoma Langerhans cell sarcoma Shprintzen-Goldberg syndrome – Life with Disease Cytokine release syndrome – Diagnostics Ewing’s sarcoma metastatic – Trials in Disease IgA nephropathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clofutriben Paclitaxel Albumin-Bound Eclitasertib Farletuzumab Ecteribulin Pristinamycin Bempedoic Acid Interferon Gamma Rifaximin Ecoo4 Dermatophagoides Farinae Upadacitinib Corticosteroids, Plain Tianeptine Cusatuzumab Ontasameran Spironolactone Pentetic Acid Batoclimab Demeclocycline Hydrochloride Eletriptan More therapies…

    Learn about Your Condition

    Autoimmune haemolytic anaemia Chronic fatigue syndrome Osteoporosis Frostbite Femoral hernia Hepatic cancer Turner's syndrome Autoimmune uveitis Monkeypox Chronic hepatitis B Testicular leiomyosarcoma Diabetic autonomic neuropathy Malignant melanoma stage II Pigmentary glaucoma Pain in extremity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Epidermolysis bullosa

  • Study on the Effects of TCP-25 Gel for Wound Healing in Patients with Epidermolysis Bullosa

    Recruiting

    2 1
    Investigated Drugs:
    • H-GLY-LYS-TYR-GLY-PHE-TYR-THR-HIS-VAL-PHE-ARG-LEU-LYS-LYS-TRP-ILE-GLN-LYS-VAL-ILE-ASP-GLN-PHE-GLY-GLU-OH
    France Greece Italy Spain Sweden

  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA
    France

  • Study on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older

    Recruiting

    4 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Diacerein
    Austria Belgium France Greece Ireland Italy +2

  • Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Apremilast
    France

  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Colestyramine
    France

  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Chloropyramine Hydrochloride
    • Chlorphenamine Maleate
    • Dexchlorpheniramine Maleate
    Austria Croatia Denmark France Germany Greece +6
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!